Lung cancer

Immutep notches upward on first lung cancer patient dosing

Immutep Ltd has dosed the first patient of its Phase 3 TACTI-004 non-small cell lung cancer…
Immune system concept ai gen

Immutep dips as safety test for flagship drug IMP761 shows no adverse effects

Immutep has reported a small-scale conceptual safety test among 5 patients using flagship drug IMP761 has…